Saliva as a Diagnostic Tool for Advancing Accessible Testing
Learn how saliva-based testing can improve access to diagnostics, reduce patient and provider costs, and have a positive impact on public health response strategies.
In this webinar, we explore how saliva-based diagnostics can be used to advance accessible and equitable healthcare solutions. We discuss the benefits of non-invasive saliva sampling, its applications in diagnosing both infectious and chronic diseases, and its influence on the diagnostic landscape. Real-world examples are shared to demonstrate how innovative protocols and programs can support testing in LMICs, improve access to care in resource-limited settings, reduce patient and provider costs, and facilitate rapid public health response efforts.
Join us to learn how saliva-based testing can offer a patient-friendly solution with the potential to transform global health outcomes.
Of interest to:
- Healthcare professionals seeking innovative diagnostic solutions.
- Public health officials who are interested in scalable, accessible testing.
- Researchers focused on non-invasive diagnostics.
- Organizations dedicated to global health equity.
- Lab managers exploring saliva-based testing protocols.
What you will learn
- The benefits of saliva as a non-invasive diagnostic sample type.
- Real-world applications of saliva-based testing for infectious and chronic diseases.
- The challenges and limitations of saliva-based diagnostics, and ongoing advancements.
Speakers
Alexandra Kitz
Director of Science, SalivaDirect, Inc.
Alexandra Kitz is the Director of Science at SalivaDirect, Inc. She brings extensive expertise in molecular diagnostics and clinical operations. With a background in developing in vitro diagnostic assays for infectious diseases and cancer, she leads the design and execution of clinical studies for FDA submissions and oversees the development of laboratory assays. Her scientific leadership ensures that SalivaDirect’s diagnostic tests are rigorously developed and validated for diverse populations, advancing the organization’s mission to expand diagnostic solutions into new areas.
Neil Spooner
Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group
Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.